| JWO | Name: | N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-2-hydroxy-2-methylpropanamide | Formula: | C27 H37 N3 O3 | SMILES: | CC(C)(C)c1ccc(cc1)N(C(=O)C(C)(C)O)C(c1cccnc1)C(=O)NC1CCCCC1 | InChi: | InChI=1S/C27H37N3O3/c1-26(2,3)20-13-15-22(16-14-20)30(25(32)27(4,5)33)23(19-10-9-17-28-18-19)24(31)29-21-11-7-6-8-12-21/h9-10,13-18,21,23,33H,6-8,11-12H2,1-5H3,(H,29,31)/t23-/m1/s1 | Definition date: | 2023-08-09 | Last modified: | 2024-09-27 | Release date: | 2024-01-24 | Identifier: | N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-2-hydroxy-2-methylpropanamide |
|
| SHV | Name: | HEPTANOIC ACID | Formula: | C7 H14 O2 | SMILES: | O=C(O)CCCCCC | InChi: | InChI=1S/C7H14O2/c1-2-3-4-5-6-7(8)9/h2-6H2,1H3,(H,8,9) | Definition date: | 2004-04-19 | Last modified: | 2024-09-27 | Identifier: | heptanoic acid |
|
| TBE | Name: | TAZOBACTAM INTERMEDIATE | Formula: | C10 H14 N4 O5 S | SMILES: | O=S(=O)C(Cn1nncc1)(C)C(C(=O)O)N/C=CC=O | InChi: | InChI=1S/C10H14N4O5S/c1-10(20(18)19,7-14-5-4-12-13-14)8(9(16)17)11-3-2-6-15/h2-6,8,11,20H,7H2,1H3,(H,16,17)/b3-2-/t8-,10-/m0/s1 | Definition date: | 2004-07-28 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-(dioxidosulfanyl)-N-[(1Z)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine |
|
| TBI | Name: | TAZOBACTAM TRANS-ENAMINE INTERMEDIATE | Formula: | C10 H14 N4 O5 S | SMILES: | O=S(=O)C(Cn1nncc1)(C)C(C(=O)O)NC=CC=O | InChi: | InChI=1S/C10H14N4O5S/c1-10(20(18)19,7-14-5-4-12-13-14)8(9(16)17)11-3-2-6-15/h2-6,8,11,20H,7H2,1H3,(H,16,17)/b3-2+/t8-,10-/m0/s1 | Definition date: | 2003-11-20 | Last modified: | 2024-09-27 | Identifier: | (3S)-3-(dioxidosulfanyl)-N-[(1E)-3-oxoprop-1-en-1-yl]-4-(1H-1,2,3-triazol-1-yl)-D-valine |
|
| TSL | Name: | TRANS-ENAMINE INTERMEDIATE OF SULBACTAM | Formula: | C8 H13 N O5 S | SMILES: | O=S(O)C(C(NC=CC=O)C(=O)O)(C)C | InChi: | InChI=1S/C8H13NO5S/c1-8(2,15(13)14)6(7(11)12)9-4-3-5-10/h3-6,9H,1-2H3,(H,11,12)(H,13,14)/b4-3+/t6-/m0/s1 | Definition date: | 2005-07-28 | Last modified: | 2024-09-27 | Identifier: | N-[(1E)-3-oxoprop-1-en-1-yl]-3-sulfino-D-valine |
|
| YOZ | Name: | (2S,5R)-5-amino-1-formyl-5-hydroxy-N-(piperidin-4-yl)piperidine-2-carboxamide | Formula: | C12 H22 N4 O3 | SMILES: | OC1(N)CCC(C(=O)NC2CCNCC2)N(C=O)C1 | InChi: | InChI=1S/C12H22N4O3/c13-12(19)4-1-10(16(7-12)8-17)11(18)15-9-2-5-14-6-3-9/h8-10,14,19H,1-7,13H2,(H,15,18)/t10-,12+/m0/s1 | Synonyms: | Relebactam, the acylated, desulfated, imine-hydrolysis intermediate | Definition date: | 2023-02-15 | Last modified: | 2024-09-27 | Release date: | 2023-08-09 | Identifier: | (2S,5R)-5-amino-1-formyl-5-hydroxy-N-(piperidin-4-yl)piperidine-2-carboxamide |
|
| SAL | Name: | 2-HYDROXYBENZOIC ACID | Formula: | C7 H6 O3 | SMILES: | O=C(O)c1ccccc1O | InChi: | InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10) | Synonyms: | SALICYLIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2-hydroxybenzoic acid |
|
| TKS | Name: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}amino)-1-oxopropan-2-yl]carbamate | Formula: | C27 H40 Cl N3 O5 S | SMILES: | C1C(CCCC1)CC(C(NC(C(S)O)CC2C(=O)NCC2)=O)NC(=O)OCC(C)(C)c3cc(Cl)ccc3 | InChi: | InChI=1S/C27H40ClN3O5S/c1-27(2,19-9-6-10-20(28)15-19)16-36-26(35)31-21(13-17-7-4-3-5-8-17)24(33)30-22(25(34)37)14-18-11-12-29-23(18)32/h6,9-10,15,17-18,21-22,25,34,37H,3-5,7-8,11-14,16H2,1-2H3,(H,29,32)(H,30,33)(H,31,35)/t18-,21-,22-,25+/m0/s1 | Definition date: | 2020-03-24 | Last modified: | 2024-09-27 | Release date: | 2020-09-30 | Identifier: | 2-(3-chlorophenyl)-2-methylpropyl [(2S)-3-cyclohexyl-1-({(1R,2S)-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]-1-sulfanylpropan-2-yl}amino)-1-oxopropan-2-yl]carbamate |
|
| J5V | Name: | N-(3-phenylprop-2-yn-1-yl)acetamide | Formula: | C11 H11 N O | SMILES: | C(c1ccccc1)#CCNC(=O)C | InChi: | InChI=1S/C11H11NO/c1-10(13)12-9-5-8-11-6-3-2-4-7-11/h2-4,6-7H,9H2,1H3,(H,12,13) | Definition date: | 2018-08-13 | Last modified: | 2024-09-27 | Release date: | 2019-12-18 | Identifier: | N-(3-phenylprop-2-yn-1-yl)acetamide |
|
| JGC | Name: | Flavin mononucleotide (semi-quinone intermediate) | Formula: | C17 H23 N4 O9 P | SMILES: | Cc1cc2N[CH]3C(=O)NC(=O)N=C3N(C[CH](O)[CH](O)[CH](O)CO[P](O)(O)=O)c2cc1C | InChi: | InChI=1S/C17H23N4O9P/c1-7-3-9-10(4-8(7)2)21(15-13(18-9)16(25)20-17(26)19-15)5-11(22)14(24)12(23)6-30-31(27,28)29/h3-4,11-14,18,22-24H,5-6H2,1-2H3,(H,20,25,26)(H2,27,28,29)/t11-,12+,13+,14-/m0/s1 | Synonyms: | [(2R,3S,4S)-5-[(4aR)-7,8-dimethyl-2,4-bis(oxidanylidene)-4a,5-dihydrobenzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] dihydrogen phosphate | Definition date: | 2022-04-27 | Last modified: | 2024-09-27 | Release date: | 2023-05-24 | Identifier: | [(2~{R},3~{S},4~{S})-5-[(4~{a}~{R})-7,8-dimethyl-2,4-bis(oxidanylidene)-4~{a},5-dihydrobenzo[g]pteridin-10-yl]-2,3,4-tris(oxidanyl)pentyl] dihydrogen phosphate |
|
| 7JZ | Name: | 2-deoxy-2,2-difluoro-beta-D-lyxo-hexopyranose | Formula: | C6 H10 F2 O5 | SMILES: | FC1(F)C(O)C(O)C(OC1O)CO | InChi: | InChI=1S/C6H10F2O5/c7-6(8)4(11)3(10)2(1-9)13-5(6)12/h2-5,9-12H,1H2/t2-,3+,4+,5-/m1/s1 | Synonyms: | 2-DEOXY-2,2-DIFLUORO-BETA-D-GALACTOPYRANOSYL-ENZYME INTERMEDIATE | Definition date: | 2009-05-19 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-2,2-difluoro-beta-D-lyxo-hexopyranose |
|
| QBZ | Name: | (2~{S},3~{S})-3-[bis(oxidanylidene)-$l^{5}-sulfanyl]-3-methyl-2-[(~{E})-3-oxidanylidenepropylideneamino]-4-(1,2,3-triaz
ol-1-yl)butanoic acid | Formula: | C10 H13 N4 O6 S | SMILES: | C[C](Cn1ccnn1)([CH](N=CCC(O)=O)C(O)=O)[S-](=O)=O | InChi: | InChI=1S/C10H13N4O6S/c1-10(21(19)20,6-14-5-4-12-13-14)8(9(17)18)11-3-2-7(15)16/h3-5,8H,2,6H2,1H3,(H,15,16)(H,17,18)/q-1/b11-3+/t8-,10-/m0/s1 | Synonyms: | Tazobactam imine intermediate | Definition date: | 2020-06-04 | Last modified: | 2024-09-27 | Release date: | 2021-06-09 | Identifier: | (2~{S},3~{S})-3-methyl-2-[(~{E})-(3-oxidanyl-3-oxidanylidene-propylidene)amino]-3-sulfinato-4-(1,2,3-triazol-1-yl)butanoic acid |
|
| R7D | Name: | N~2~-{(2R)-2-hydroxy-2-[4-(trifluoromethyl)phenyl]acetyl}-N-[(pyridin-2-yl)methyl]-L-cysteinamide | Formula: | C18 H18 F3 N3 O3 S | SMILES: | SCC(C(NCc1ncccc1)=O)NC(C(c2ccc(cc2)C(F)(F)F)O)=O | InChi: | InChI=1S/C18H18F3N3O3S/c19-18(20,21)12-6-4-11(5-7-12)15(25)17(27)24-14(10-28)16(26)23-9-13-3-1-2-8-22-13/h1-8,14-15,25,28H,9-10H2,(H,23,26)(H,24,27)/t14-,15+/m0/s1 | Definition date: | 2020-02-04 | Last modified: | 2024-09-27 | Release date: | 2020-08-05 | Identifier: | N~2~-{(2R)-2-hydroxy-2-[4-(trifluoromethyl)phenyl]acetyl}-N-[(pyridin-2-yl)methyl]-L-cysteinamide |
|
| RIP | Name: | beta-D-ribopyranose | Formula: | C5 H10 O5 | SMILES: | OC1C(O)COC(O)C1O | InChi: | InChI=1S/C5H10O5/c6-2-1-10-5(9)4(8)3(2)7/h2-9H,1H2/t2-,3-,4-,5-/m1/s1 | Synonyms: | beta-D-ribose | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | beta-D-ribopyranose |
|
| CR9 | Name: | 2-{5-[AMINO(IMINIO)METHYL]-6-FLUORO-1H-BENZIMIDAZOL-2-YL}-6-[(2-METHYLCYCLOHEXYL)OXY]BENZENOLATE | Formula: | C21 H23 F N4 O2 | SMILES: | [O-]c4c(OC1CCCCC1C)cccc4c3nc2cc(c(F)cc2n3)C(=[NH2+])N | InChi: | InChI=1S/C21H23FN4O2/c1-11-5-2-3-7-17(11)28-18-8-4-6-12(19(18)27)21-25-15-9-13(20(23)24)14(22)10-16(15)26-21/h4,6,8-11,17,27H,2-3,5,7H2,1H3,(H3,23,24)(H,25,26)/t11-,17-/m0/s1 | Synonyms: | CRA_11092 | Definition date: | 2003-03-14 | Last modified: | 2024-09-27 | Identifier: | 2-{5-[amino(iminio)methyl]-6-fluoro-1H-benzimidazol-2-yl}-6-{[(1S,2S)-2-methylcyclohexyl]oxy}phenolate |
|
| GBS | Name: | 4-carbamimidamidobenzoic acid | Formula: | C8 H9 N3 O2 | SMILES: | NC(=N)Nc1ccc(cc1)C(=O)O | InChi: | InChI=1S/C8H9N3O2/c9-8(10)11-6-3-1-5(2-4-6)7(12)13/h1-4H,(H,12,13)(H4,9,10,11) | Synonyms: | Nafamostat, bound form | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 4-carbamimidamidobenzoic acid |
|
| DMG | Name: | N,N-DIMETHYLGLYCINE | Formula: | C4 H9 N O2 | SMILES: | O=C(O)CN(C)C | InChi: | InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7) | Synonyms: | DIMETHYLGLYCINE | Definition date: | 2000-03-20 | Last modified: | 2024-09-27 | Identifier: | N,N-dimethylglycine |
|
| TOG | Name: | 4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3
-ium-2-yl]-4-oxidanyl-butanoic acid | Formula: | C16 H24 N4 O10 P2 S | SMILES: | Cc1ncc(C[n+]2c(C)c(CCO[P](O)(=O)O[P](O)(O)=O)sc2[C-](O)CCC(O)=O)c(N)n1 | InChi: | InChI=1S/C16H24N4O10P2S/c1-9-13(5-6-29-32(27,28)30-31(24,25)26)33-16(12(21)3-4-14(22)23)20(9)8-11-7-18-10(2)19-15(11)17/h7,21H,3-6,8H2,1-2H3,(H,22,23)(H,27,28)(H2,17,18,19)(H2,24,25,26) | Synonyms: | ThDP and decarboxylated 2-oxoglutarate adduct, covalent intermediate I, carboanion form | Definition date: | 2015-11-17 | Last modified: | 2024-09-25 | Release date: | 2016-06-22 | Identifier: | 4-[3-[(4-azanyl-2-methyl-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl(phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-4-oxidanyl-butanoic acid |
|
| A1AIY | Name: | (8R)-8-[4-(trifluoromethyl)phenyl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]-5,8-dihydro-1,7-naphthyridine-7(6H)-carboxamide | Formula: | C19 H17 F6 N3 O | SMILES: | FC(F)(F)c1ccc(cc1)C1c2ncccc2CCN1C(=O)NC(C)C(F)(F)F | InChi: | InChI=1S/C19H17F6N3O/c1-11(18(20,21)22)27-17(29)28-10-8-12-3-2-9-26-15(12)16(28)13-4-6-14(7-5-13)19(23,24)25/h2-7,9,11,16H,8,10H2,1H3,(H,27,29)/t11-,16+/m0/s1 | Definition date: | 2024-03-26 | Last modified: | 2024-08-16 | Release date: | 2024-08-21 | Identifier: | (8R)-8-[4-(trifluoromethyl)phenyl]-N-[(2S)-1,1,1-trifluoropropan-2-yl]-5,8-dihydro-1,7-naphthyridine-7(6H)-carboxamide |
|
| A1IG2 | Name: | Bomedemstat FAD adduct | Formula: | C36 H42 F N9 O16 P2 | SMILES: | Cc1cc2N(C[CH](O)[CH](O)[CH](O)CO[P](O)(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)ncnc45)C6=NC(=O)NC(=O)[C]67[CH](C[CH](O)N7c2cc1C)c8ccc(F)cc8 | InChi: | InChI=1S/C36H42FN9O16P2/c1-15-7-20-21(8-16(15)2)46-25(49)9-19(17-3-5-18(37)6-4-17)36(46)33(42-35(54)43-34(36)53)44(20)10-22(47)27(50)23(48)11-59-63(55,56)62-64(57,58)60-12-24-28(51)29(52)32(61-24)45-14-41-26-30(38)39-13-40-31(26)45/h3-8,13-14,19,22-25,27-29,32,47-52H,9-12H2,1-2H3,(H,55,56)(H,57,58)(H2,38,39,40)(H,43,53,54)/t19-,22+,23-,24-,25-,27+,28-,29-,32-,36+/m1/s1 | Definition date: | 2024-07-02 | Last modified: | 2024-07-05 | Release date: | 2024-07-10 |
|
| A1H0M | Name: | 6-bromanyl-1,3-benzothiazol-2-amine | Formula: | C7 H5 Br N2 S | SMILES: | Nc1sc2cc(Br)ccc2n1 | InChi: | InChI=1S/C7H5BrN2S/c8-4-1-2-5-6(3-4)11-7(9)10-5/h1-3H,(H2,9,10) | Definition date: | 2023-12-15 | Last modified: | 2024-06-14 | Release date: | 2024-06-19 | Identifier: | 6-bromanyl-1,3-benzothiazol-2-amine |
|
| MED | Name: | D-METHIONINE | Formula: | C5 H11 N O2 S | SMILES: | O=C(O)C(N)CCSC | InChi: | InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m1/s1 | Definition date: | 2002-01-18 | Last modified: | 2023-11-03 | Identifier: | D-methionine |
|
| IWE | Name: | Azosemide | Formula: | C12 H11 Cl N6 O2 S2 | SMILES: | N[S](=O)(=O)c1cc(c(NCc2sccc2)cc1Cl)c3[nH]nnn3 | InChi: | InChI=1S/C12H11ClN6O2S2/c13-9-5-10(15-6-7-2-1-3-22-7)8(12-16-18-19-17-12)4-11(9)23(14,20)21/h1-5,15H,6H2,(H2,14,20,21)(H,16,17,18,19) | Synonyms: | 2-chloranyl-5-(1~{H}-1,2,3,4-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide | Definition date: | 2022-04-14 | Last modified: | 2023-04-21 | Release date: | 2023-04-26 | Identifier: | 2-chloranyl-5-(1~{H}-1,2,3,4-tetrazol-5-yl)-4-(thiophen-2-ylmethylamino)benzenesulfonamide |
|
| PN9 | Name: | (4Z)-4-({[(1E)-1-carboxy-3-(methylsulfanyl)propylidene]azaniumyl}methylidene)-2-methyl-5-[(phosphonooxy)methyl]-1,4-dihydropyridin-3-olate | Formula: | C13 H19 N2 O7 P S | SMILES: | O=C(O)C(CCSC)=[NH+]C=C1/C([O-])=C(C)NC=C1COP(=O)(O)O | InChi: | InChI=1S/C13H19N2O7PS/c1-8-12(16)10(6-15-11(13(17)18)3-4-24-2)9(5-14-8)7-22-23(19,20)21/h5-6,14,16H,3-4,7H2,1-2H3,(H,17,18)(H2,19,20,21)/b10-6-,15-11+ | Synonyms: | PLP-Met adduct intermediate in zwitterionic form | Definition date: | 2022-01-14 | Last modified: | 2022-05-27 | Release date: | 2022-06-01 | Identifier: | (4Z)-4-({[(1E)-1-carboxy-3-(methylsulfanyl)propylidene]azaniumyl}methylidene)-2-methyl-5-[(phosphonooxy)methyl]-1,4-dihydropyridin-3-olate |
|
| 8QY | Name: | N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-N'-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea | Formula: | C19 H27 N3 O2 S | SMILES: | Oc1ccc(cc1)CC(CNC(=O)NC(C)Cc1ccsc1)N(C)C | InChi: | InChI=1S/C19H27N3O2S/c1-14(10-16-8-9-25-13-16)21-19(24)20-12-17(22(2)3)11-15-4-6-18(23)7-5-15/h4-9,13-14,17,23H,10-12H2,1-3H3,(H2,20,21,24)/t14-,17-/m0/s1 | Definition date: | 2021-09-27 | Last modified: | 2022-04-15 | Release date: | 2022-04-20 | Identifier: | N-[(2S)-2-(dimethylamino)-3-(4-hydroxyphenyl)propyl]-N'-[(2S)-1-(thiophen-3-yl)propan-2-yl]urea |
|